| Income Statement |
| Total Revenue | 49.95M |
|
| Revenues (USD) | 49.95M |
| Cost of Revenue | 18.38M |
| Gross Profit | 31.57M |
| Operating Expenses | 34.38M |
| Research and Development Expense | 8.74M |
| Selling, General and Administrative Expense | 25.63M |
| Operating Income | -2.80M |
| Income Tax Expense | 292.00K |
| Net Income | -2.96M |
| Net Income Common Stock | -2.96M |
| Net Income Common Stock (USD) | -2.96M |
| Consolidated Income | -2.96M |
| Earnings per Basic Share | -0.07 |
| Earnings per Basic Share (USD) | -0.07 |
| Earnings per Diluted Share | -0.07 |
| Earning Before Interest & Taxes (EBIT) | -2.66M |
| Earning Before Interest & Taxes (USD) | -2.66M |
| Weighted Average Shares | 44.97M |
| Weighted Average Shares Diluted | 44.97M |
| Balance Sheet |
| Cash and Equivalents | 26.97M |
| Cash and Equivalents (USD) | 26.97M |
| Trade and Non-Trade Receivables | 27.77M |
| Current Assets | 72.47M |
| Property, Plant & Equipment Net | 54.20M |
| Total Assets | 210.54M |
| Debt Current | 4.24M |
| Total Debt | 22.69M |
| Current Liabilities | 96.34M |
| Debt Non-Current | 18.45M |
| Total Liabilities | 115.10M |
| Accumulated Retained Earnings (Deficit) | -239.57M |
| Accumulated Other Comprehensive Income | -1.16M |
| Shareholders Equity | 95.44M |
| Shareholders Equity (USD) | 95.44M |
| Assets Non-Current | 138.07M |
| Total Debt (USD) | 22.69M |
| Deferred Revenue | 63.21M |
| Goodwill and Intangible Assets | 78.46M |
| Liabilities Non-Current | 18.76M |
| Trade and Non-Trade Payables | 7.53M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.12M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.80M |
| Capital Expenditure | -1.80M |
| Net Cash Flow from Investing | -1.80M |
| Net Cash Flow from Operations | 3.41M |
| Effect of Exchange Rate Changes on Cash | 1.19M |
| Share Based Compensation | 2.63M |